Eva‐Maria Paulus - Concepedia

Author

Eva‐Maria Paulus

Also Known As

E Paulus, E. M. Paulus, E. Paulus, E.-M. Paulus, E.M. Paulus, Eva-Maria Paulus, Eva‐Maria Paulus, Michael Duerr, Paulus, Eva-Maria

Publications

712

Citations

H-Index

Concepts

All Affiliations

Novartis (Germany)Charité - Universitätsmedizin Berlin Universität Hamburg Medizinische Hochschule Hannover Heidelberg University

About

Eva‐Maria Paulus is an author at Novartis (Germany) specializing in medicine, pharmacology, and alzheimer's disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	212
2	Social Sciences	1	1	111
3	Gastroenterology	1	1	16
4	Hepatology	1	1	16
5	Neurology	1	1	111

Eva‐Maria Paulus

Publications

629

Citations

H-Index

Page 1

	Year	Citations
Nicergoline in senile dementia of alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study B. Saletu, Eva‐Maria Paulus, L Linzmayer, Psychopharmacology NeuropsychologyAlzheimer's DiseaseAlzheimer TypeEeg/erp Mapping StudySenile Dementia	1995	111
Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation Martina Sterneck, Gernot Kaiser, Nils Heyne, American Journal of Transplantation	2014	94
Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study Hans Hoerauf, Nicolas Feltgen, Eva‐Maria Paulus, American Journal of Ophthalmology Diabetic RetinopathyOcular DiseaseVitreous BodyComrade COphthalmology	2016	85
Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study Klemens Budde, Frank Lehner, Claudia Sommerer, American Journal of Transplantation	2012	84
EEG Brain Mapping in Diagnostic and Therapeutic Assessment of Dementia B. Saletu, P. Anderer, Eva‐Maria Paulus, Alzheimer Disease & Associated Disorders	1991	72
Head‐to‐head comparison of ranibizumab PRN versus single‐dose dexamethasone for branch retinal vein occlusion (COMRADE‐B) Lars‐Olof Hattenbach, Nicolas Feltgen, Thomas Bertelmann, Acta Ophthalmologica	2017	64
Omeprazole Impairs the Absorption of Mycophenolate Mofetil But Not of Enteric‐Coated Mycophenolate Sodium in Healthy Volunteers Martin G. Kees, Thomas Steinke, Stefan Moritz, The Journal of Clinical Pharmacology	2011	52
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial Klemens Budde, Martin Zeier, Oliver Witzke, Nephrology Dialysis Transplantation	2017	35
Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study Bernhard Manger, Falk Hiepe, Peter Wimmer, Clinical and Experimental Gastroenterology	2015	16
Improvement in Gastrointestinal and Health-related Quality of Life Outcomes After Conversion From Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium in Liver Transplant Recipients Martina Sterneck, Utz Settmacher, Tom M. Ganten, Transplantation Proceedings Enteric-coated Mycophenolate SodiumTransplantationHepatologyLife OutcomesLiver Transplant Recipients	2014	16

Page 1